usbiostock2018-07-10 04:25
$OncoCyte Corporation (OCX)$ 公司宣布肺癌血液诊断平台DetermaVu™临床样本研究数据,结果显示其下一代测序平台可改善诊断效率。查看全文
Guoran2018-04-06 22:02
$OncoCyte Corporation(OCX)$ ocx关注度还不够,意味着还要上涨。ocx和bioc是一类公司,估值巨大差异的原因:前者待字闺中;后者嫁了好多次!不必当真,我买的后者。没有OCX查看全文
$Oncocyte(OCX)$ 8-K Current report, item 3.01 Accession Number: 0001493152-24-027086 Act: 34 Size: 205 KB 网页链接
$Oncocyte(OCX)$ 8-K Current report, items 5.07 and 8.01 Accession Number: 0001493152-24-026335 Act: 34 Size: 235 KB 网页链接
$Oncocyte(OCX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026272 Size: 5 KB 网页链接
$Oncocyte(OCX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026273 Size: 5 KB 网页链接
$Oncocyte(OCX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026274 Size: 5 KB 网页链接
$Oncocyte(OCX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001493152-24-024979 Size: 3 KB 网页链接
$Oncocyte(OCX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-024981 Size: 11 KB 网页链接
$Oncocyte(OCX)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001493152-24-024108 Act: 34 Size: 242 KB 网页链接
$Oncocyte(OCX)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001493152-24-022576 Act: 33 Size: 142 KB 网页链接
$Oncocyte(OCX)$ 8-K Current report, item 5.02 Accession Number: 0001493152-24-022193 Act: 34 Size: 204 KB 网页链接